Company discusses bladder cancer detection

Predictive Biosciences Inc. announced the publication of pilot study results on its urinary biomarker approach to bladder cancer detection.

In a press release, the Lexington company said the results appear in in the November issue of the Journal of Urology.

"We believe that the application of our non-invasive assay will enable clinicians to focus their attention on those patients with a high likelihood of bladder cancer, while continuing to monitor those who are cancer-free in a relatively simple and efficient manner," Anthony P. Shuber, chief technology officer of Predictive Biosciences, said in a statement.

The company cited American Cancer Society data that note that bladder cancer is the fifth most common cancer in the United States and the ninth most common cancer in the world today. (Globe Staff)